Eric Schmidt is a managing director and senior research analyst. He covers over 20 large-, mid-, and small-cap biotechnology stocks. Schmidt has been recognized in polls conducted by Alpha Magazine, Institutional Investor, Reuters, and The Wall Street Journal. Prior to joining Cowen in 1998 he was a vice president covering the biotechnology sector for UBS Securities. He holds a Bachelor of Arts in chemistry from the University of Pennsylvania and a Ph.D. in biochemistry from the Massachusetts Institute of Technology.
Due to permission requirements, not all quotes are shown.